Skip to content

The effects of CCBT-I combined with Beethoven's Psychosomatic Sleep Therapy System on Sleep Quality and Cognitive Function in Patients with Short-term Insomnia Disorder

The effects of CCBT-I combined with Beethoven's Psychosomatic Sleep Therapy System on Sleep Quality and Cognitive Function in Patients with Short-term Insomnia Disorder

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043922
Enrollment
Unknown
Registered
2021-03-05
Start date
2021-03-30
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Short-term Insomnia Disorder

Interventions

observation group:Beethoven's Psychosomatic Sleep Therapy
Control group :Cognitive behavioral therapy for insomnia

Sponsors

Zhumadian Psychiatric Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Age between 18 and 65, male or female; (2) Primary school education or above; (3) Short-term insomnia patients meeting ICSD-3 diagnostic criteria, PSQI > 7 points; (4) HAMA < 7 points, HAMD < 7 points; (5) Have not taken related drugs for sleep treatment or stable sedative and hypnotic drugs for nearly 1 month (the type and dosage of drugs remain unchanged for 1 consecutive month); (6) Able to use mobile phones and mobile devices, proficient in operating procedures of insomnia cognitive behavioral therapy management system software.

Exclusion criteria

Exclusion criteria: (1) Patients with other mental disorders meeting the diagnostic criteria of ICD-10; (2) Patients with severe impairment of heart, liver, kidney and respiratory function or other serious diseases of various systems, such as epilepsy; (3) Metal implants were implanted in the body, and antidepressants and other psychotropic drugs were used in the past 2 months; (4) Have received or are currently undergoing non-convulsive electroconvulsive therapy or transcranial magnetic stimulation or transcranial direct current stimulation or transcranial alternating current stimulation.

Design outcomes

Primary

MeasureTime frame
PSQI;ISI;Sleep latency;Proportion of stage 3 sleep;

Countries

China

Contacts

Public ContactLvfeng Zhang

Zhumadian Psychiatric Hospital

zhanglvfeng0411@126.com+86 15939629365

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026